celecoxib and am 251

celecoxib has been researched along with am 251 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bosetti, F; Tomita, YA; Toscano, CD; Ueda, Y; Vicini, S1
Bakhle, YS; CamĂȘlo, VM; Dos Reis, WG; Faraco, A; Francischi, JN; Paiva-Lima, P; Rezende, RM1
Adinolfi, B; Breschi, MC; Carpi, S; Costa, B; Da Pozzo, E; Fogli, S; Martini, C; Nieri, P; Pellegrino, M; PodestĂ , A; Romanini, A1
Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS1

Other Studies

4 other study(ies) available for celecoxib and am 251

ArticleYear
Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.
    Brain research bulletin, 2008, Mar-28, Volume: 75, Issue:5

    Topics: Analysis of Variance; Animals; Autoradiography; Celecoxib; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Enzyme-Linked Immunosorbent Assay; gamma-Aminobutyric Acid; Hippocampus; Kainic Acid; Male; Membrane Potentials; Membrane Proteins; Mice; Mice, Knockout; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Seizures; Statistics, Nonparametric; Sulfonamides; Synaptic Transmission

2008
Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system.
    Pharmacology, 2012, Volume: 89, Issue:3-4

    Topics: Analgesics; Animals; Carrageenan; Celecoxib; Central Nervous System; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Inflammation; Male; Naltrexone; Pain; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfonamides

2012
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.
    Anti-cancer drugs, 2015, Volume: 26, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Calcium Channels; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclic AMP; Cyclooxygenase 2; Drug Inverse Agonism; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Melanoma; Mutation; Nerve Tissue Proteins; Piperidines; Proto-Oncogene Proteins B-raf; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Skin Neoplasms; Sulfonamides; Transient Receptor Potential Channels; TRPA1 Cation Channel

2015
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
    Neuropharmacology, 2020, Volume: 163

    Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecoxib; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Oxidopamine; Pain; Parkinson Disease; Piperidines; Pyrazoles; Thienamycins

2020